Biopharmaceutical industry clients now have direct access to 365体育亚洲唯一官方入口’s clinical contract research organization (CRO) services and expertise through a new portal: 365体育亚洲唯一官方入口商业生命科学(365体育亚洲唯一官方入口 CLS).


“The website showcases our strengths in all areas of clinical trials support so that current and new clients and partners can appreciate how we will work with them step-by-step from trial design to regulatory processes, 全程提供专业知识和经验,” 南希diani, Vice President and Director of 365体育亚洲唯一官方入口’s 临床试验 Practice.

“我们仍然365体育亚洲唯一官方入口, with all the professional services support capabilities we have always offered,”她继续. “This website details what we can do for commercial biopharma clients. 一起前进, 365体育亚洲唯一官方入口 CLS的口号, defines our mission: to collaborate with our clients to face the challenges of study implementation and develop solutions that help bring new drugs and therapeutics to market faster. Our goal is to deliver work our clients can stand behind and results that help them address some of the world’s most pressing health challenges.”


“365体育亚洲唯一官方入口 has decades of experience to draw on as we continue to meet this specialized market’s needs,” 惠特尼·史密斯、副主任. “Our staff has the flexibility and 创造力 to tackle challenges from trial design to regulatory processes. 为了彰显他们的才华,我们提供 我们的团队页面 一键访问我们的技术线索, 项目经理, 生物统计学, 流行病学家, 和更多的. These are the people who will work with our clients as an extension of their team—as trusted partners—and who are committed to finding solutions and moving projects forward.”


This new website serves as a gateway for clients to tap into the wide range of services we provide, 增加了 劳伦Laimon,高级项目总监. “我们有专业知识, 创造力, and efficiencies to contribute through the entire project lifecycle, or we can tailor our support to exactly what is needed at any time on a project. We have also stepped in at the last minute to take over where needed,” she explains. “在选择CRO时, 韦斯特知道我们的客户面临的风险是什么, 我们提供项目管理, 临床试验设计, biostatistical支持, 工地管理及监察, 规管事务及运作, 数据管理, 药物警戒, 数据监控, 并为他们能够支持的结果撰写医学文章.”

365体育亚洲唯一官方入口 has been providing support for 35+ years to the biopharma industry. On the website, we highlight 5 areas of expertise, providing case studies to illustrate our work. 一如既往地, we place a high priority on customized attention and client confidentiality regarding client products and services.

疫苗. 了35年, 365体育亚洲唯一官方入口 has supported vaccine development studies and vaccine evaluations, 包括艾滋病毒, 人乳头状瘤病毒, 黑素瘤, 水痘, 和流感. We have also established virtual networks to gather data on infection and complications, 和疫苗有效性.

儿科研究. 韦斯特的服务涵盖了这些至关重要的研究, from early-phase pharmacokinetic/pharmacodynamics safety studies to later phase efficacy studies. 用于寨卡病毒研究, 例如, we provided extensive expertise in the investigation of adverse maternal/fetal outcomes and effects of the virus on children’s long-term growth and development. 也, the sponsor of a novel gene therapy for subjects with a rare inherited form of vision loss needed a replacement CRO to take over at the last minute for complete project man年龄ment support. 365体育亚洲唯一官方入口 provided a solid foundation for the integrity of the data moving forward, ensuring our sponsor could count on an optimally designed and statistically sound study.

罕见和新发疾病. Zika and COVID-19 are just examples of how rare or emerging diseases can penetrate the population with devastating consequences. 365体育亚洲唯一官方入口 has been a domestic and global partner in responding to biomedical and public health needs.

肿瘤学. 365体育亚洲唯一官方入口 has been a leader in supporting oncology research throughout the entire lifecycle of a clinical program, from a phase 1 trial through Food and Drug Administration submission. Our work and support for the National Cancer Institute’s Cancer Trials Support Unit has been internationally recognized for research that leads to improving the lives of cancer patients with new treatments, 控制, 和治疗方法.

传染病. 减缓传播. 弯曲的曲线. 关闭病毒. 从艾滋病毒到COVID-19, 365体育亚洲唯一官方入口 is participating in groundbreaking research of a range of diseases to reduce transmission, 开发治疗, 寻找可以拯救生命的疗法.

365体育亚洲唯一官方入口 has long been the established leader in survey research; some clients may be under the misconception that’s all we do. 韦斯特是一家调查研究公司,除此之外还有很多其他功能, and we bring the same level of excellence to all areas of our work,“强调女士. diani. “我们在联邦和商业工作中都发挥了我们的优势, being well versed in federal regulations for conducting clinical trials. 客户是谁或者他们的资金来源并不重要,”她补充道, “他们想把他们的药物和疗法推向市场. One of the benefits of working with 365体育亚洲唯一官方入口 is that we offer innovative solutions to fit each unique program. 这就是我们有别于其他cro的地方. And we continue to work with every client as if they are our only client.”

“We are excited to introduce the 365体育亚洲唯一官方入口 Commercial Life Sciences website to our clients and partners,” Ms. diani笔记, “and to continue providing forward-thinking and results-oriented services for many years to come!”

The website showcases our strengths in all areas of clinical trials support so that current and new clients and partners can appreciate how we will work with them step-by-step from trial design to regulatory processes, 全程提供专业知识和经验,

- 南希diani,临床试验副总裁兼主任


关于我们 职业生涯

医疗保险中心 & 医疗补助服务
sirius xm公司
U.S. 农业部
U.S. 教育部
U.S. 卫生与公众服务部
U.S. 司法部
U.S. 交通部
U.S. 退伍军人事务部
福布斯2021年最适合女性的雇主福布斯2021年最具多样性的雇主Forbes 2021: America's Best Midsize Employer Powered by Statista 福布斯2021年退伍军人最佳雇主

365体育亚洲唯一官方入口 is an Equal Opportunity Employer and does not discriminate on the basis of race, 信条, color, 宗教, 性, 国家的起源, 年龄, 资深地位, 残疾, 婚姻状况, 性取向, 国籍, 遗传信息, 性别认同或性别表达, 或适用法律规定的其他受保护状态. 通知员工 & 申请人.